William Guyer - 16 May 2025 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Reporting relationship: Chief Development Officer
Issuer ticker: CORT
Reported as of: 16 May 2025
Net transaction value: -$1,694,542
SEC form: 4
Accepted by SEC: 20 May 2025, 19:35:58 UTC
Prior SEC filing: 08 May 2025
Next SEC filing: 12 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Joseph Douglas Lyon, as attorney-in-fact for William Guyer

Key filing fact

William Guyer filed Form 4 for CORCEPT THERAPEUTICS INC (CORT) on 20 May 2025.

Key facts

This page summarizes William Guyer's Form 4 filing for CORCEPT THERAPEUTICS INC (CORT).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 20 May 2025, 19:35.

Change

Previous filing in this sequence was filed on 08 May 2025.
Current net transaction value: -$1,694,542.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001879013 Primary reporting owner

Guyer William

Relationship: Chief Development Officer
Address: C/O CORCEPT THERAPEUTICS INCORPORATED, 101 REDWOOD SHORES PARKWAY, REDWOOD CITY
Signature: /s/ Joseph Douglas Lyon, as attorney-in-fact for William Guyer
Signature date: 20 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CORT transaction

Common Stock

Options Exercise

Transaction value: $698,472
Shares: +32,262
Change %: +588%
Price: $21.65
Shares after: 37,749
Date: 16 May 2025
Ownership: Direct

CORT transaction

Common Stock

Sale

Transaction value: $2,393,014
Shares: -32,262
Change %: -85%
Price: $74.17
Shares after: 5,487
Date: 16 May 2025
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CORT transaction Derivative

Stock option (right to buy)

Options Exercise

Transaction value: $0
Shares: -32,262
Change %: -7.3%
Price: $0.000000
Shares after: 410,000
Date: 16 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 32,262
Exercise price: $21.65
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 3 footnotes

Footnote F1

The transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction.

Footnote F2

Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $73.94 to $74.66 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

Footnote F3

Fully exercisable.

SEC remarks

The power of attorney under which this form was signed is on file with the Commission.